BTK. Also presented at the ASH Annual Meeting were the results from the first randomised phase...

Stereotactic body radiotherapy (SBRT) is an established treatment for previously unirradiated spinal metastases, however...

Patients newly diagnosed with acute myeloid leukaemia (AML) who are eligible for intensive chemotherapy fare significantly...

New research presented at the 67th American Society of Hematology (ASH) Annual Meeting in December 2025...

First results from the phase 3 GIMEMA ALL2820 trial suggest chemotherapy-free combination treatment outperforms a combination...

The first curative lung cancer surgeries connected to the Lung Health Check pilot programme have taken...

In November 2025, the US Food and Drug Administration (FDA) approved epcoritamab with rituximab and lenalidomide...

The absence of circulating tumour cells (CTCs) defines a subtype of multiple myeloma (MM) with unique...

Ciltacabtagene autoleucel (cilta-cel) has demonstrated unprecedented response rates and progression-free survival (PFS)...

For most patients, the moment a doctor utters the words “you have cancer” is not simply...

Dr Iseult Browne, Royal Marsden Hospital, London, UK, delivered a presentation titled ‘Integrating circulating tumour DNA...

In 2001, Ireland became one of the first countries in the world to publish a national...